FDA accepts for review a DBV Technologies BLA for its investigational Viaskin peanut immunotherapy for treating peanut-allergic children ages four to ...
President Trump claims that the pharmaceutical industry is secretly plotting the demise of his presidency and supporting the current impeachment inqui...
Federal Register notice: FDA corrects a notice that appeared in 8/20 Federal Register announcing a Fit for Use Pilot Program Invitation for the Clinic...
FDA approves AstraZenecas self-administration version of Fasenra (benralizumab) Pen in a pre-filled, single-use auto-injector as an add-on maintenance...
United Health Products files a PMA for HemoStyp, an absorbable hemostatic dressing for use in abdominal, cardiovascular, thoracic and vascular surgica...
FDA grants Janssen Pharmaceutical a breakthrough therapy designation for niraparib, an orally-administered poly ADP-ribose polymerase inhibitor, for t...
Public Citizen challenges President Trumps assertion that his actions are responsible for lower drug prices.
Federal Register notice: FDA makes available a final guidance entitled Investigational Enzyme Replacement Therapy Products: Nonclinical Assessment.